These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20066738)

  • 1. Hepatopoietin Cn suppresses apoptosis of human hepatocellular carcinoma cells by up-regulating myeloid cell leukemia-1.
    Chang J; Liu Y; Zhang DD; Zhang DJ; Wu CT; Wang LS; Cui CP
    World J Gastroenterol; 2010 Jan; 16(2):193-200. PubMed ID: 20066738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of hepatopoietin Cn in the development of human hepatocellular carcinoma.
    Zhu BD; Li XL; Liu Y; Chang J; Liu Y; Zhang DD; Wang Q; Ren J; Cui CP
    Clin Exp Metastasis; 2010 Dec; 27(8):571-80. PubMed ID: 20683644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
    Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
    J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
    Koehler BC; Urbanik T; Vick B; Boger RJ; Heeger S; Galle PR; Schuchmann M; Schulze-Bergkamen H
    World J Gastroenterol; 2009 Dec; 15(47):5924-35. PubMed ID: 20014456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Des-gamma-carboxy prothrombin (DCP) antagonizes the effects of gefitinib on human hepatocellular carcinoma cells.
    Cui SX; Zhang YS; Chu JH; Song ZY; Qu XJ
    Cell Physiol Biochem; 2015; 35(1):201-12. PubMed ID: 25591763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatopoietin Cn (HPPCn) Generates Protective Effects on Acute Liver Injury.
    Li N; Liu FJ; Li DD; Sun CX; Li J; Qu MH; Cui CP; Zhang DJ
    Front Pharmacol; 2019; 10():646. PubMed ID: 31333446
    [No Abstract]   [Full Text] [Related]  

  • 8. Production of hepatopoietin Cn in high-cell-density cultures of recombinant Escherichia coli and detection of its antioxygen activity.
    Liu Y; Li XL; Zhang DD; Wang Q; Liu Y; Liu DM; Wu CT; Cui CP
    Mol Biotechnol; 2011 Feb; 47(2):111-9. PubMed ID: 20676803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the HGF/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression.
    Fu R; Jiang S; Li J; Chen H; Zhang X
    Med Oncol; 2020 Mar; 37(4):24. PubMed ID: 32166604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
    Steinway SN; Dang H; You H; Rountree CB; Ding W
    PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
    BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of anaplastic lymphoma kinase promotes apoptosis and suppresses proliferation in human hepatocellular carcinoma.
    Yu Z; Zhao R
    Anticancer Drugs; 2018 Jul; 29(6):513-519. PubMed ID: 29570100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lappaconitine Sulfate Inhibits Proliferation and Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells through the Reactive Oxygen Species-Dependent Mitochondrial Pathway.
    Zhang X; Ma J; Song N; Guo Y; Hui L; Sang C
    Pharmacology; 2020; 105(11-12):705-714. PubMed ID: 32062649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro.
    Qu Z; Wu J; Wu J; Luo D; Jiang C; Ding Y
    J Exp Clin Cancer Res; 2016 Sep; 35(1):159. PubMed ID: 27716356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling.
    Yu J; Xia X; Dong Y; Gong Z; Li G; Chen GG; Lai PBS
    Theranostics; 2021; 11(5):2123-2136. PubMed ID: 33500715
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of 12-lipoxygenase reduces proliferation and induces apoptosis of hepatocellular carcinoma cells in vitro and in vivo.
    Xu XM; Yuan GJ; Deng JJ; Guo HT; Xiang M; Yang F; Ge W; Chen SY
    Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):193-202. PubMed ID: 22484589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein phosphatase 2A mediates JS-K-induced apoptosis by affecting Bcl-2 family proteins in human hepatocellular carcinoma HepG2 cells.
    Liu L; Huang Z; Chen J; Wang J; Wang S
    J Cell Biochem; 2018 Aug; 119(8):6633-6643. PubMed ID: 29693750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.